US 7,572,810 B2
Alkene piperidine derivatives as antiviral agents
Tao Wang, Farmington, Conn. (US); Ying Han, Cheshire, Conn. (US); John F. Kadow, Wallingford, Conn. (US); Zhongxing Zhang, Madison, Conn. (US); and Nicholas A. Meanwell, East Hampton, Conn. (US)
Assigned to Bristol-Myers Squibb Company, Princeton, N.J. (US)
Filed on May 16, 2007, as Appl. No. 11/749,445.
Claims priority of provisional application 60/811898, filed on Jun. 08, 2006.
Prior Publication US 2007/0287730 A1, Dec. 13, 2007
Int. Cl. A61K 31/445 (2006.01); A61K 31/4545 (2006.01); A61P 31/12 (2006.01); C07D 215/20 (2006.01); C07D 295/00 (2006.01)
U.S. Cl. 514—314  [514/330; 546/177; 546/314] 4 Claims
 
1. A compound defined by the following formula, or pharmaceutically acceptable salts thereof:

OG Complex Work Unit Drawing